Marlowe plc
Annual Report and Financial Statements
for the year ended 31 March 2022
Contents
Highlights & overview
- At a glance
- 2022 key highlights
- Group structure
Strategic report
4 Chairman's statement
- Marlowe's Vision: End-to-end compliance
- Operating in highly attractive markets
- Chief Executive's report
- Investment proposition
- Our software offering
- Q&As with our CTO
- Building our leading eLearning platform
- KPIs
- Marlowe's model for creating growth
- Governance, Risk and Compliance
- WorkNest
- Testing, Inspection and Certification
- Hydro-X- Our acquisition strategy in action
- Chief Financial Officer's review
- Products, Planet, People
- Directors' duties
- Risk management
Corporate governance
- Board of Directors
- Directors' report
- Corporate governance statement
- Letter from the chair of the remuneration committee
- Directors' remuneration report
- Statement of Directors' responsibilities
- Independent Auditor's report
Financial statements
- Consolidated statement of comprehensive income
- Consolidated statement of changes in equity
- Consolidated statement of financial position
- Consolidated statement of cash flows
- Notes to the Group financial statements
- Company statement of changes in equity
- Company statement of financial position
- Company accounting policies
- Notes to the Company Financial Statements
Additional information
137 Trading record, financial calendar and further information
137 Officers and advisers
To download the full Annual Report and
Financial Statements, and for further information about Marlowe visit www.marloweplc.com
Strong financial performance
Revenue | FY22 | |||||||||||||||||||||
£315.9m | ||||||||||||||||||||||
FY21 | ||||||||||||||||||||||
£192.0m | ||||||||||||||||||||||
£315.9m | FY19 | £128.5m | CAGR | |||||||||||||||||||
FY20 | £185.4m | |||||||||||||||||||||
+65% | ||||||||||||||||||||||
FY18 | +41% | |||||||||||||||||||||
£80.6m | ||||||||||||||||||||||
Adjusted EBITDA1 | FY22 | |||||||||||||||||||||
£54.4m | ||||||||||||||||||||||
FY21 | ||||||||||||||||||||||
£28.7m | ||||||||||||||||||||||
£54.4m | FY19 | £11.0m | CAGR | |||||||||||||||||||
FY20 | £22.1m | |||||||||||||||||||||
+90% | ||||||||||||||||||||||
+66% | ||||||||||||||||||||||
FY18 | £7.2m | |||||||||||||||||||||
Adjusted PBT2 | FY22 | |||||||||||||||||||||
£38.1m | ||||||||||||||||||||||
FY21 | ||||||||||||||||||||||
£17.1m | ||||||||||||||||||||||
£38.1m | FY19 | £8.9m | CAGR | |||||||||||||||||||
FY20 | £13.2m | |||||||||||||||||||||
+123% | ||||||||||||||||||||||
FY18 | £5.8m | +60% | ||||||||||||||||||||
Adjusted basic | FY22 | |||||||||||||||||||||
37.7p | ||||||||||||||||||||||
earnings per share3 | FY21 | |||||||||||||||||||||
25.0p | ||||||||||||||||||||||
37.7p | FY19 | 18.8p | CAGR | |||||||||||||||||||
FY20 | 23.6p | |||||||||||||||||||||
+51% | ||||||||||||||||||||||
FY18 | +28% | |||||||||||||||||||||
14.0p | ||||||||||||||||||||||
Statutory results | FY22 | FY21 |
Operating profit | £10.5m | £1.0m |
Profit/(loss) before tax | £5.9m | £(1.6)m |
Earnings per share - basic | 0.8p | (3.1)p |
- Adjusted earnings before interest, tax, depreciation and amortisation ("EBITDA") is EBITDA before separately disclosed acquisition and other costs as disclosed in note 4 and 5.
- Adjusted profit before tax ("PBT") is PBT before separately disclosed acquisition and other costs as presented within the Chief Financial Officer's review on page 32.
- Adjusted earnings per share is earnings per share calculated on adjusted PBT. These are all non-IFRS measures.
Further information about these measures and the reasons why we believe they are important for an understanding of the performance of the business is provided in the Chief Financial Officer's review on page 32.
Marlowe plc Annual Report and Financial Statements 2022
At a glance
We deliver compliance services and software across health & safety, HR & employment law, occupational health, fire safety & security, and water & air hygiene - all of which are vital to the well-being of our customers' operations and are invariably governed by stringent regulation.
Our proposition helps our clients reduce risk, assure regulatory compliance, and achieve total peace of mind.
3m | 3,000 | 40m+ | 50+ |
service visits & | fee earning | assets tested | specialist |
compliance | |||
advice provided | and inspected | compliance | |
experts | |||
annually | each year | services | |
1m+ | 50,000+ c.25% | ~40% | |
software | customers across | UK commercial | customers |
users | premises | using multiple | |
the UK | |||
service-clients | Marlowe services | ||
Marlowe's unique strength is that it provides a range of closely related regulated compliance services and software platforms, each of which is delivered by one of our specialist businesses. Individually, these businesses are leaders in their fields but together form a group that can provide our customers with a comprehensive and integrated approach to their safety, regulatory compliance, business efficiency and employee welfare.
Our clients can be found in most office complexes, high streets, leisure facilities, manufacturing plants, industrial estates, include thousands of SMEs, large corporates, facilities, property management providers, local authorities, NHS trusts, and FTSE 100 companies.
information Additional statements Financial governance Corporate report Strategic overview & Highlights
marloweplc.com | 1 |
2022 key highlights
Marlowe delivered further strong financial and strategic progress as the leader in compliance services & software.
Revenue growth
2022: £315.9m
2021: £192.0m
Underlying organic growth1
Cash conversion 2
Combined underlying cash conversion for the 24-month period
Net zero carbon emissions4
Run rate revenue 3
+65% +90%
+9% 85%
91% 9%
2035 £314m
£434m £77m
Adjusted EBITDA growth
2022: £54.4m
2021: £28.7m
Recurring revenue
Recurring revenue is defined as subscription revenue, software license revenue and multi-year contracted services
SaaS ARR
SaaS ARR is defined as the annual value of the recurring revenue components of subscriptions for our software products, normalised to a one-year period
FY22 capital deployed on acquisitions
Based on initial capital deployed
Run rate
EBITDA 3
- Organic revenue growth % on a like-for-like basis is defined as the year-on-year growth of our entire business. This includes the growth or decline of acquisitions from the day of completion, by including their performance from the corresponding prior period. Organic revenue excludes the
estimated distortive impact from the prior-period effects of COVID-19 in FY21. Including this estimated impact, organic growth was +11%.
- In FY21 the group benefited from a significant reduction in working capital as a result of COVID related VAT and payroll tax deferrals. These
factors have normalised in the current year. To get a normalised cash flow a 24-month period has been used.
-
Run-rateis based on year-end performance annualised and adjusted for post year end acquisitions.
4 Scope 1 and Scope 2 GNG emissions
2 | Marlowe plc Annual Report and Financial Statements 2022 |
Group structure
Marlowe organises its end-to-end compliance solution across two divisions: GRC and TIC. GRC is a consulting and software focused division and TIC specialises in field-based assurance. Together they allow us to offer a full compliance package.
report Strategic overview & Highlights
Governance, Risk
and Compliance (GRC)
Consulting and software solutions to mitigate business risk and ensure legally compliant governance standards
Testing, Inspection
and Certification (TIC)
Recurring testing and inspection regimes to certify properties and systems are safe and compliant
governance Corporate
RECURRING SERVICE EXAMPLE
Compliance | Health & | Employment | Occupational | Fire Safety | Water | |||||
Software | Safety | Law/HR | Health | & Security | & Air Hygiene | |||||
ALL UNDERPINNED BY EVER-EVOLVING REGULATIONS
• H&S at Work Act 1974 | • Regulatory Reform (Fire Safety) Order 2005 | |
• UK GDPR Act 2021 | • Corporate Manslaughter Act 2007 | |
• Management of H&S 1999 | • H&S at Work Act 1974 | |
• Employment Rights Act 1996 | • | ACoP L8 |
• Employment Relations Act 1999 | • HSG 274 / TR19 | |
• Workplace (Health, Safety and Welfare) | • | COSHH |
Regulations 1992 |
£185m | 30.1% | £249m | 13.8% | |||
Run rate | Adj. EBITDA | Run rate | Adj. EBITDA | |||
revenue | margin | revenue | margin | |||
information Additional statements Financial
marloweplc.com | 3 |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Marlowe plc published this content on 01 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 July 2022 07:52:04 UTC.